Case series of prophylactic S-1-based treatment in solid tumour patients with severe cardiac comorbidity
Presentation
Safety and efficacy of S-1-based treatment in colorectal cancer patients who switched to S-1 after development of cardiotoxicity on fluoropyrimidine-based adjuvant or neoadjuvant treatment